Document is current
Any future updates will be listed below
-
Authors
Tanaka, Tomoharu https://orcid.org/0009-0001-3888-6631
Morimoto, Satoru
Ito, Keitaro
Yasutake, Kaori
Kato, Chris
Shinozaki, Munehisa https://orcid.org/0000-0002-1116-2713
Suda, Kota
Maeda, Takeshi
Yato, Yoshiyuki
Nakamura, Masaya
Okano, Hideyuki https://orcid.org/0000-0001-7482-5935
Nagoshi, Narihito https://orcid.org/0000-0001-8267-5789
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd | Chugai Pharmaceutical (N/A)
Japan Society for the Promotion of Science London (JP21H05278; JP22K15736)
- License Information
-
More Information
Article History
Received: 27 April 2025
Accepted: 24 September 2025
First Online: 27 October 2025
Competing interests
: M.N. and H.O. are co-founders of K Pharma Inc. All other authors declare no competing interests.
